Answers are grounded in this paper and cite their sources.
Systematic review evaluates the efficacy and safety of Serenoa repens in treating benign prostatic disorders, suggesting its potential benefits.
This systematic review comprehensively evaluates literature from the past 5 years on the efficacy and safety of Serenoa repens in the treatment of benign prostatic disorders, either as monotherapy or in combination with other treatments.
No takes yet. Share an insight, caveat, or question.
Schwartzmann et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: